Table: begin end state 1 20 cytoplasmic 21 41 transmembrane 42 46 non-cytoplasmic 47 65 transmembrane 66 85 cytoplasmic 86 106 transmembrane 107 123 non-cytoplasmic 124 144 transmembrane 145 153 cytoplasmic 154 178 transmembrane 179 198 non-cytoplasmic 199 221 transmembrane 222 240 cytoplasmic 241 262 transmembrane 263 286 non-cytoplasmic 287 308 transmembrane 309 335 cytoplasmic 336 355 transmembrane 356 360 non-cytoplasmic 361 380 transmembrane 381 400 cytoplasmic 401 423 transmembrane 424 428 non-cytoplasmic 429 448 transmembrane 449 464 cytoplasmic
Input: >AO356_11625 FitnessBrowser__pseudo5_N2C3_1:AO356_11625 MSGTQTSDNLAQGLKPRHVTMLSIAGVIGAGLFVGSGHAIAAAGPAVLLAYAAAGALVVL VMRMLGEMAVASPDTGSFSTYADRAIGHWAGFTIGWLYWWFWVLVIPLEANAAATILHAW FPNVAIWVFTLVITLLLTVTNLFSVKNYGEFEFWFALVKVVAIIGFIGLGLMAIFGVLPT SQVSGVSHLFDTQGFLPNGMGAVLGAILTTMFSFMGTEIVTIAAAESKNPGQQISKATNS VIWRIGLFYLVSIFIVVALVPWNDPLLASVGSYQTVLERMGIPNAKLIVDIVVLVAVTSC LNSALYTASRMMFSLGKRGDAPAVSQRTNKSGTPHWAVMLSTGAAFLAVFANYVAPAAVF EFLLASSGAIALLVYLVIAVSQLRMRKQRMARGEKIAFSMWLFPGLTYAVIVFIVGALTI MLFQEAHRVEILATGLLSVLVVISGVLIQRRRIVKAGSPVPTIG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server